Loading clinical trials...

Goal-oriented Intervention in Parkinson's Disease | Clinical Trials | Clareo Health

COMPLETEDNA

Goal-oriented Intervention in Parkinson's Disease

Effects of a Goal-oriented Upper-limb Intervention in Patients With Parkinson's Disease

NCT02938819•Universidad de Granada

Summary

Upper-limb disorders in patients with Parkinson's disease include decreased speed and amplitude of movements, difficulty in sequential tasks, and disrupted execution of fine manipulative hand activities.The aim of the study was to evaluate the effects of home-based goal-oriented upper limb intervention in patients with Parkinson's disease.

Detailed Description

Parkinson's disease is a neurodegenerative neurological disorders involving progressive impairment in motor, mood and cognitive functions. Movement disorders have a negative impact on individual's ability to perform well-learned motor skills. These include akinesia, bradykinesia, rigidity and tremor at rest. A goal-planning process should be useful to ensure that patients agree on the goals of rehabilitation. Thus, the purpose of the study was to evaluate the effects of home-based goal-oriented upper limb intervention in patients with Parkinson's disease.

Eligibility

Age

50 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Clinical diagnosis of Parkinson's Disease.
•Stage II-III of disease progression as defined by the Hoehn and Yahr scale.
•Upper limbs impairment

Exclusion Criteria

•Clinical signs of dementia or psychiatric disturbance.
•Comprehension deficits that prevented them from following verbal commands.
•Visual or acoustic limitations.
•A neurologic condition other than Parkinson's Disease.
•Musculoskeletal disorders and/or if they had previous trauma or fracture of upper extremity.

Locations (1)

Department of Physical Therapy

Granada, Granada, Spain

Key Dates

Start Date

August 1, 2016

Primary Completion Date

October 1, 2016

Completion Date

December 1, 2016

Last Updated

December 14, 2016

Enrollment

ACTUAL participants

Conditions

Parkinson's Disease

Interventions

Goal-oriented upper-limb intervention

OTHER

Standard upper limb intervention

OTHER

Research Into the Safety of a New Agent (VT-5006) in People With and Without Parkinson's Disease

NCT07310264

Healthy Volunteers (HV)Parkinson's Disease (PD)

View study

RECRUITINGNA

Deep Brain Stimulation Therapy in Movement Disorders

NCT02119611

Parkinson's Disease

View study

RECRUITINGNA

Adaptive DBS Algorithm for Personalized Therapy in Parkinson's Disease (ADAPT-PD) China Study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 14, 2016Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Goal-oriented Intervention in Parkinson's Disease

Inclusion Criteria

Exclusion Criteria

Research Into the Safety of a New Agent (VT-5006) in People With and Without Parkinson's Disease

Deep Brain Stimulation Therapy in Movement Disorders

Adaptive DBS Algorithm for Personalized Therapy in Parkinson's Disease (ADAPT-PD) China Study

A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease

Effect of Striatal Temporal Interference Stimulation on Language Processing in Neurodegenerative Diseases

SAD Study in Patients With Parkinson's Disease and Motor Fluctuations